Scientific Advisory Board

Michael Collins, M.B.A

MedTech

COO, Cor Medical Ventures
Fmr. V.P. Digital Solutions and R&D, Zimmer Biomet
M.B.A., Ball State University (Entrepreneurship)
M.S., University of Akron (Biomedical Engineering)
B.S., Purdue University (Mechanical Engineering

Dr. Christopher Gallen, M.D.

Neurology, CNS, Pain

Chairman, CEO at Treos Bio Limited
Ex-CEO at Wex Pharma, SK Biopharma-USA, Neuromed, Combinatorx
VP Clinical Ops at Wyeth; VP Medical Research-CNS at Pharmacia
President at Premier Research {CRO]
M.D./Ph.D., Emory University School of Medicine
B.A., University of Florida (Philosophy)

Dr. Michael A. Mont, M.D.

Joint Arthroplasty, Orthopaedic Devices

Attending Orthopaedic Surgeon, Rubin Institute, Baltimore, Maryland
Former Chairman Orthopaedic Surgery, Cleveland Clinic
M.D. University of Pennsylvania, Perelman School of Medicine
B.A. Johns Hopkins University

Dr. Thomas Malcolm Ph.D.

Gene Editing/Delivery, Infectious Diseases

Founder/CSO at Caravan Biologix
CSO/COO at Kermode Biotechnologies
Ex-CEO/Founder at Excision Biotherapeutics
Ph.D.. University of British Columbia (Biochemistry, Molecular Biology)
B.S. University of Victoria (Biochemistry and Microbiology)

Dr. Kenneth Ng, M.D.

Anesthesiology

Attending anesthesiologist, RWJ Cooperman Barnabas
Attending anesthesiologist, Hackensack University Medical Center
Partner, Thessalus Capital Management
M.D., SUNY Downstate College of Medicine B.A., New York University (Biochemistry)

Dr. Matthias Schroff, Ph.D.

Immuno-oncology

CEO, Inceptor Bio
Ex-CEO at Exicure (+COO/CSO), Vaximm, Mologen
Ph.D., Freie University Berlin (Molecular Biology)
B.S. Leibniz Univ. Hannover (Biochemistry)

Dr. Curtis Scribner, M.D., M.B.A.

Rare Diseases, Regulatory

Scientific Advisor, Bond Biosciences
Regulatory Affairs at Quintiles, Intarcia, RRD International
Deputy Director of OBRR and CBER at FDA
M.D., University of Colorado College of Medicine
M.B.A. University of Maryland
B.A., Grinnell College